Evidence map›Paper›PMID 27286715›Full record

ArticleJournal of diabetes science and technology2016

Round Table Discussion on Inpatient Use of Continuous Glucose Monitoring at the International Hospital Diabetes Meeting.

Amisha Wallia, Guillermo E Umpierrez, Stanley A Nasraway, David C Klonoff, PRIDE Investigators

Registry-linked trialAbstract readConference Proceedings
In one paragraph

Article in Journal of diabetes science and technology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06693115 (The Use of Continuous Glucose Monitoring With Patients Undergoing a New Subcutaneous Insulin Protocol for Mild to Moderate Diabetic Ketoacidosis or Hyperosmolar Hyperglycemic State), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06693115 nawithdrawnnot on this mapstarted 2026, after this paper: background citation

The Use of Continuous Glucose Monitoring With Patients Undergoing a New Subcutaneous Insulin Protocol for Mild to Moderate Diabetic Ketoacidosis or Hyperosmolar Hyperglycemic State

TypeinterventionalSponsorHealthPartners InstituteRan2026 to 2026Enrolled0ConditionsDiabetic Ketoacidosis, HyperglycemiaArmsCGM with alerts
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Article
  4. Facilitators and Barriers to Nursing Implementation of Continuous Glucose Monitoring (CGM) in Critically Ill Patients With COVID-19.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2021
    Article
  5. Article
  6. Article
  7. Observational
  8. Glucose Management Technologies for the Critically Ill.Journal of diabetes science and technology · 2019
    Review
  9. Article
  10. Article
  11. Review
  12. Perioperative Management of Hyperglycemia and Diabetes in Cardiac Surgery Patients.Endocrinology and metabolism clinics of North America · 2018
    Review
  13. Review
  14. Inpatient Continuous Glucose Monitoring and Glycemic Outcomes.Journal of diabetes science and technology · 2017
    Review
  15. Consensus Statement on Inpatient Use of Continuous Glucose Monitoring.Journal of diabetes science and technology · 2017
    Article
  16. Review
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amisha WalliaNorthwestern University, Feinberg School of Medicine, Division of Endocrinology, Metabolism, and Molecular Medicine, Chicago, IL, USA a-wallia@northwestern.edu.
Guillermo E UmpierrezEmory University School of Medicine, Atlanta, GA, USA.
Stanley A NasrawayTufts Medical Center, Boston, MA, USA.
David C KlonoffMills-Peninsula Health Services, Diabetes Research Institute, San Mateo, CA, USA.
PRIDE Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In May 2015 the Diabetes Technology Society convened a panel of 27 experts in hospital medicine and endocrinology to discuss the current and potential future roles of continuous glucose monitoring (CGM) in delivering optimum health care to hospitalized patients in the United States. The panel focused on 3 potential settings for CGM in the hospital, including (1) the intensive care unit (ICU), (2) non-ICU, and (3) continuation of use of home CGM in the hospital. The group reviewed barriers to use and solutions to overcome the barriers. They concluded that CGM has the potential to improve the quality of patient care and can provide useful information to help health care providers learn more about glucose management. Widespread adoption of CGM by hospitals, however, has been limited by added costs and insufficient outcome data.

Indexed as

InpatientsBlood GlucoseHospitalsHumansMonitoring, PhysiologicBlood Glucosediabetesglucosehospitalhypoglycemiainpatient continuous glucose monitor

Identifiers

PMID27286715
PMCPMC5032965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.